Skip to content
+91 22 42221111
compliance@sudarshanpharma.com
Search:
Sudarshan Pharma Industries Ltd.
Pharma and Specialty Chemicals
Sudarshan Pharma Industries Ltd.Sudarshan Pharma Industries Ltd.
  • Home
  • Company Overview
    • About us
    • Business Model
    • Executive Leadership
    • Our Locations
    • Awards & Accolades
    • Corporate Presentation
  • Business Segments
    • Chemicals
      • Specialty Chemicals
      • Purification, LR, AR, material as per IP, BP, USP
      • Manufacturing
    • Pharmaceuticals
      • Ethical division
      • Generic Institution supply
      • Manufaturing Export
      • Intermediates Manufacturing
      • API Manufacturing
      • API Contract Manufacturing
      • Inhalers Manufacturing
  • Investors/Disclosures under Reg 46 of LODR
    • Corporate Information
    • Overview
    • Financial Information
    • Reports & Presentation
    • Disclosures
      • Board of Directors
      • Board Meeting Intimation and Outcome
      • Shareholders Meeting
      • Corporate Action
      • Newspaper Advertisements
      • Grievance Redressal
      • Business Details
      • Key Managerial Persons
      • Shareholding Pattern
      • SEBI (SAST) Regulations, 2011
      • SEBI (PIT) Regulations 2015
      • Investors Complaint
    • Other Investor Information
      • Codes and Policies
      • Investor Relation
      • Investor Presentations
      • Corporate Governance
      • Corporate Announcements
      • Annual Reports and Annual Returns
      • Financial Results
      • Related Party Transactions
      • Statement of Deviation / Variation
      • Statutory Disclosure
      • Initial Public Offering
  • Sustainability
    • Focus Areas
    • CSR
  • Media
    • Press Release
    • News & Events
    • Gallery
    • Clientele
  • Careers
    • People & Culture
    • Recruitment Process
    • Current Openings
    • Apply Now
  • Contact
    • Contact us
    • FAQ
  • Home
  • Company Overview
    • About us
    • Business Model
    • Executive Leadership
    • Our Locations
    • Awards & Accolades
    • Corporate Presentation
  • Business Segments
    • Chemicals
      • Specialty Chemicals
      • Purification, LR, AR, material as per IP, BP, USP
      • Manufacturing
    • Pharmaceuticals
      • Ethical division
      • Generic Institution supply
      • Manufaturing Export
      • Intermediates Manufacturing
      • API Manufacturing
      • API Contract Manufacturing
      • Inhalers Manufacturing
  • Investors/Disclosures under Reg 46 of LODR
    • Corporate Information
    • Overview
    • Financial Information
    • Reports & Presentation
    • Disclosures
      • Board of Directors
      • Board Meeting Intimation and Outcome
      • Shareholders Meeting
      • Corporate Action
      • Newspaper Advertisements
      • Grievance Redressal
      • Business Details
      • Key Managerial Persons
      • Shareholding Pattern
      • SEBI (SAST) Regulations, 2011
      • SEBI (PIT) Regulations 2015
      • Investors Complaint
    • Other Investor Information
      • Codes and Policies
      • Investor Relation
      • Investor Presentations
      • Corporate Governance
      • Corporate Announcements
      • Annual Reports and Annual Returns
      • Financial Results
      • Related Party Transactions
      • Statement of Deviation / Variation
      • Statutory Disclosure
      • Initial Public Offering
  • Sustainability
    • Focus Areas
    • CSR
  • Media
    • Press Release
    • News & Events
    • Gallery
    • Clientele
  • Careers
    • People & Culture
    • Recruitment Process
    • Current Openings
    • Apply Now
  • Contact
    • Contact us
    • FAQ

Author Archives: @Sudarshan.Pharma

View Banner For Intermediates Manufacturing Unit V

October 18, 2024

View View Banner For Intermediates Manufacturing Unit VView Our Brochure

Read more

View Banner For Inorganic Chemical Manufacturing Unit IV

October 18, 2024

View View Banner For Inorganic Chemical Manufacturing Unit IVView Our Brochure

Read more

View Banner For Finish Formulation WHO GMP Approved Unit II

October 18, 2024

View View Banner For Finish Formulation WHO GMP Approved Unit IIView Our Brochure

Read more

View Banner For Excipients For Pharma Products

October 18, 2024

View View Banner For Excipients For Pharma ProductsView Our Brochure

Read more

View Banner For Chlorination and Bromination

October 18, 2024

View View Banner For Chlorination and Bromination BannerView Our Brochure

Read more

View Banner For Chemical Division

October 18, 2024

View Chemical Division BannerView Our Brochure

Read more

View Banner For Avolon Exim

October 18, 2024

View Avolon Exim BannerView Our Brochure

Read more

View Banner For API Manufacturing Unit 1

October 18, 2024

View API Manufacturing Unit 1 BannerView Our Brochure

Read more

Extraordinary General Meeting held on 30th September 2024

October 3, 2024
Read more
←12345→
Business segments
  • Specialty Chemicals
  • Intermediates
  • Ethical division
  • Generic Institution supply
  • Exports
  • API
Quick Links
  • Home
  • About us
  • Executive Leadership
  • Corporate Presentation
  • CSR
  • People in culture
  • Current openings
Investors
  • Overview
  • Financial Information
  • Reports & Presentation
  • Stock Information
Contact Us
Sudarshan Pharma Ind. Ltd.
  • Address
    301, 3rd Floor, Aura Biplex Landmark Kalyan Jewellers, S V Road, Borivali (W), Mumbai - 400092. Maharashtra. India.
  • Contact
    +91-22-42221111 (Board Line)
    +91-22-42221123 / +91-22-42221160
  • E-mail
    For Export:
    sudarshangroupexports@gmail.com
    For Local:
    sachinchemicals@gmail.com
    purchase@sudarshanpharma.com

Find us on:

Facebook page opens in new windowLinkedin page opens in new window
Sudarshan Pharma Industries Ltd.
© All Rights Reserved 2019 Sudarshan Pharma | Website Design by Apex Solutions
  • Privacy Policy
Useful links
Go to Top